Hydroxychloroquine has evolved from a sleepy anti-malarial drug into a partisan litmus test over the future of COVID-19 treatment. Dan and Axios health care reporter Bob Herman dig into what we know about the drug, what we still don't, and why both matter.

Go deeper

16 mins ago - Science

The risk of branding NASA's wins

Illustration: Eniola Odetunde/Axios

President Trump, like some of his predecessors, is branding NASA's recent wins as political, presidential accomplishments even though they are the result of efforts that span administrations.

Why it matters: Experts warn that partisan politicking with NASA can lead to whiplash that leaves the agency scrambling to chase new goals whenever a new administration arrives in Washington.

Death spiral for consumers

Illustration: Eniola Odetunde/Axios

Despite some recent good news about dwindling household debt, the financial health of U.S. consumers is rapidly deteriorating — and families with children are faring the worst.

Why it matters: As Congress deadlocks over pandemic relief and President Trump issues executive orders of dubious potency, many Americans are suffering from a quintuple whammy: unemployment, overdue rent, mounting bills, food insecurity and health fears.

The end of Hong Kong's political freedom is here

Illustration: Annelise Capossela/Axios

The end of Hong Kong's relatively free political system is no longer looming. It's here.

Why it matters: The Chinese Communist Party is already wielding the new national security law it forced upon Hong Kong just over a month ago.

  • And through the extraterritoriality enshrined in the new law, Beijing has signaled that its push against pro-democracy activism is going global.